2025 MIPS Measure #505

ID: 505

DESCRIPTION:

The percentage of patients aged 18 years and older with a mental and/or substance use disorder AND suicidal thoughts, behaviors or risk symptoms who demonstrated a reduction in suicidal ideation and/or behavior symptoms based on results from the Columbia-Suicide Severity Rating Scale ‘Screen Version’ or ‘Since Last Visit’ (C-SSRS), within 120 days after an index assessment.

DENOMINATOR:

Patients aged 18 and older with a mental and/or substance use disorder with suicidal ideation and/or behavior symptoms OR deemed a suicide risk based on their clinician’s evaluation at an encounter with an index assessment completed using the C-SSRS during the denominator identification period

INSTRUCTIONS:

This measure is to be submitted a minimum of once per performance period for patients with mental and/or substance use disorder AND suicidal thoughts, behaviors, or risk symptoms who are seen during the denominator identification period. This measure is intended to reflect the quality of services provided for patients with a mental and/or substance use disorder diagnosis who are identified as being at increased suicide risk based upon the results of the C-SSRS or clinician determination during the denominator identification period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.

SCREENING:

Completion of a clinical or diagnostic tool used to identify people at risk of developing or having certain disease or condition, even in the absence of symptoms.

Examples of PatientLink Screening tools for this measure: